Pratibha Binder, MD

Articles by Pratibha Binder, MD

Dr. Binder on the Use of Immune Checkpoint Inhibitors in Endometrial Cancer Treatment

November 16th 2022

Pratibha Binder, MD, discusses how the introduction of novel immune checkpoint inhibitors into frontline treatment strategies could ameliorate unmet needs in endometrial cancer.

Pratibha Binder, MD, of Moores Cancer Center, UC San Diego Health

Dr. Binder on Key Trials Improving the Treatment Landscape for Endometrial Cancer

ByPratibha Binder, MD

November 3rd 2022

Pratibha Binder, MD, discusses key trials improving the array of treatment options for patients with endometrial cancer.

Pratibha Binder, MD

Articles by Pratibha Binder, MD

Dr. Binder on the Use of Immune Checkpoint Inhibitors in Endometrial Cancer Treatment

Dr. Binder on Key Trials Improving the Treatment Landscape for Endometrial Cancer

Latest Updated Articles

Trending on OncLive

FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC

Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC

SC Daratumumab Plus VRd Expands Options in Newly Diagnosed, Transplant-Ineligible Myeloma

HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts

Latest ACS Cancer Statistics Report Outlines Notable Gains, Remaining Gaps Across Tumor Types